AlphaTON Capital Corp. (ALP) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18

Key dataSep 18, 2026

Open$4.62

From 52W high−99.15%

Volume55522.00

Market cap$7.21M

P/E (TTM)—

P/S (TTM)74.3x

Div yield—

Key dataSep 18, 2026

Open

$4.62

From 52W high

−99.15%

Volume

55522.00

Market cap

$7.21M

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−0.1x

P/E (TTM)

—

RSI (14)

35.0

MomentumView details →

1D Return

+3.33%

YTD Return

−84.37%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

−0.1x

EV/Sales

49.9x

P/S (TTM)

74.3x

P/B (TTM)

1.0x

ProfitabilityView details →

Gross Margin

100.00%

Net Margin

—

EBITDA Margin

—

ROE (TTM)

−600.69%

ROA (TTM)

−222.35%

Asset Turnover

0.00x

GrowthView details →

Revenue YoY

—

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

—

EPS CAGR 3Y

+26.92%

EBITDA YoY

—

MomentumView details →

1D Return

+3.33%

YTD Return

−84.37%

1Y Return

−98.45%

RSI (14)

35.0

vs 50D SMA

−46.37%

vs 200D SMA

−78.02%

Capital & dividendView details →

Debt/Equity

0.02x

Current Ratio

0.31x

Quick Ratio

0.31x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

−$3.50

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

97000.00

Net Income (TTM)

−43.42M

Op. CF (TTM)

−31.54M

Next earningsNov 25, 2026 →

Latest newsMore news →

No recent news for ALP.

Similar companies

Enveric Biosciences, Inc.ENVB CNS Pharmaceuticals, Inc.CNSP InMed Pharmaceuticals Inc.INM Imunon, Inc.IMNN Curanex Pharmaceuticals Inc Common StockCURX Traws Pharma, Inc.TRAW Find similar companies →

Latest newsMore news →

No recent news for ALP.